Subcommittee on Research and Technology Hearing - Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients

Subcommittee on Research and Technology | 2318 Rayburn House Office Building Washington, D.C. 20515 | Jul 17, 2014 9:00am

Witnesses

Dr. Harold Varmus, Director, National Cancer Institute (NCI) at the National Institutes of Health (NIH)
Truth in Testimony

Dr. Marc Tessier-Lavigne, President and Carson Family Professor, Laboratory of Brain Development and Repair, The Rockefeller University
Truth in Testimony

Dr. Jay Keasling, Hubbard Howe Jr. Distinguished Professor of Biochemical Engineering, University of California, Berkeley; Professor, Department of Chemical & Biomolecular Engineering, University of California, Berkeley; Professor Department of Bioengineering, University of California, Berkeley; Director, Synthetic Biology Engineering Research Center
Truth in Testimony

Dr. Craig Venter, Founder, Chairman, and Chief Executive Officer, J. Craig Venter Institute, Synthetic Genomics, Inc., and Human Longevity, Inc.
Truth in Testimony